What Genetics does

Genetics Maven (Metis Genetics, LLC.) is a direct-to-consumer genetic counseling service founded in 2015 and headquartered in the Addison/Richardson, Texas area. The company connects individual patients nationwide with American Board of Genetic Counseling (ABGC)-board certified genetic counselors, each of whom averages 12-14 years of clinical experience. Services are delivered through a HIPAA-compliant web platform available across all 50 U.S. states, covering clinical areas that include Family Planning/Prenatal, Hereditary Cancer, and additional specialty areas such as pediatrics and neurology. Since founding, the company has served more than 215,000 patients, with reported 96% patient satisfaction and 94% of patients indicating they feel more informed after counseling.

The platform operates on a per-session pricing model at $175 per 45-minute appointment, allowing patients to self-book counseling without a physician referral — a structural departure from the traditional clinical pathway. The platform is integrated with 10 genetic testing laboratory partners (Ambry, Baylor Genetics, BioReference, Fulgent, GeneDX, Invitae, LabCorp, Myriad, Natera, and Sonic Healthcare), enabling patients to either bring existing test results or order new tests as part of the counseling workflow. The technology stack centers on a HIPAA-compliant web application with encrypted PHI storage, secure scheduling, and counselor-client communication channels.

Genetics Maven is structured as a private LLC with a headcount of 11-50 employees. Revenue is generated primarily through the per-session fee, with the laboratory relationships serving as a referral and fulfillment channel rather than a direct revenue stream. The business model is therefore a high-volume, transactional B2C clinical services model in which unit economics are driven by sessions completed, counselor utilization, and patient acquisition cost against a $175 price point.

Name

Genetics

Legal name

Metis Genetics, LLC.

Website

https://geneticsmaven.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

Genetics Maven is a direct-to-consumer genetic counseling service, founded in 2015 and operating in all 50 U.S. states, that connects individual patients with ABGC-board certified counselors via a HIPAA-compliant web platform at $175 per 45-minute session.

Ownership category

akta.pro rank

Product category

Genetic Counseling Services

NAICS

Other Individual and Family Services (624190)

SIC

Services-Health Services (8000)

akta.pro primary industry

Genetic Counseling & Prenatal Testing Telehealth (carrier screening, NIPT counseling) (HLALAHAK)

akta.pro secondary industry

Genetic & Prenatal Testing Laboratories (HLAFAMAH)

Keywords

• Genetic counseling
• Telehealth video sessions
• Prenatal genetic screening
• Hereditary cancer testing
• HIPAA-compliant platform

Headquarters

HQ city

Addison

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Genetic Counseling Sessions: Direct-to-consumer genetic counseling sessions billed at a fixed per-session rate. Patients pay $175 for a 45-minute appointment. The company does not accept insurance directly but provides a Superbill form for patients to submit claims to their insurance provider for potential reimbursement.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Genetics Maven delivers direct-to-consumer genetic counseling services through a HIPAA-compliant web-based platform that connects patients with ABGC-board certified genetic counselors via secure video conference or phone call. The offering includes pre-test counseling, post-test result interpretation, family planning/prenatal screening (carrier screening, NIPS/NIPT), and hereditary cancer risk assessment, priced at $175 per 45-minute session without requiring a healthcare provider referral.

Product overview

Metis Genetics (operating as Genetics Maven) is a genetic counseling platform offering two core services: Genetic Counseling & Optional Testing and Genetic Test Result Review. Services are accessible through a HIPAA-compliant web-based video conferencing platform or phone call. The company specializes in two clinical areas — Family Planning/Prenatal (including carrier screening and non-invasive prenatal screening) and Hereditary Cancer (including hereditary cancer predisposition and diagnostic cancer testing). Genetic test results from partner laboratories (Ambry, Baylor Genetics, BioReference, Fulgent, GeneDX, Invitae, LabCorp, Myriad, Natera, and Sonic Healthcare) can be uploaded or faxed for review during counseling sessions. The platform does not perform genetic testing itself but helps patients understand what test results mean for them and their families.

Differentiator

Problem solved

Functional benefit

Products and services

• Pre-Test Genetic Counseling & Optional Testing A pre-test genetic counseling service where ABGC-certified genetic counselors educate patients on genetic testing options, benefits, limitations, and possible test results based on personal and family medical history, supporting informed decisions about whether testing is appropriate. Sessions run 45–60 minutes.
• Post-Test Genetic Test Result Review Post-test genetic counseling that helps patients understand complex genetic test results, their personal and familial implications, inheritance patterns, and recommended next steps. Sessions range from 30 minutes to one hour, with patients able to upload or fax results in advance.
• Family Planning / Prenatal Genetic Counseling Genetic counseling focused on reproductive health, including carrier screening and non-invasive prenatal screening (NIPS/NIPT), for individuals and reproductive partners planning a family. Targets family planning and prenatal decision-making needs.
• Hereditary Cancer Genetic Counseling Genetic counseling for hereditary cancer risk assessment, including hereditary cancer predisposition testing and diagnostic cancer testing, helping patients understand results and recommended preventative care and screening actions.
• HIPAA-Compliant Video Conferencing Counseling Platform HIPAA-secure web-based portal enabling patients direct access to genetic counseling via video conference or phone call without requiring a healthcare provider referral. Operates between 8am and 5pm CST, Monday–Friday.

Quantifiable outcome

• 96% patient satisfaction rating
• +1 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration10 records

Feature2 records

Partnerships

Two partnerships are on record, tiered core.

• Genetic Testing Laboratories (Multiple)coreStrategic or Co-development PartnerMetis Genetics partners with multiple genetic testing laboratories including Ambry, Baylor Genetics, BioReference, Fulgent, GeneDX, Invitae, LabCorp, Myriad, Natera, and Sonic Healthcare to provide patients with appropriate test options based on their personal and family medical history.
• Healthcare SystemscoreStrategic or Co-development PartnerMetis Genetics partners with healthcare systems to provide a range of genetic counseling services alongside their direct-to-consumer offerings.

Scale indicators6 records

Recent moves5 records

Expansion highlights3 records

Broad incumbents

• Invitae: Invitae is a large genetic testing company serving clinicians with hereditary cancer, reproductive health, and rare disease tests, and offers post-test genetic counseling resources. Comparable to Metis in reproductive and hereditary cancer counseling but operates as a testing-first incumbent rather than a counseling-first platform.
• Quest Diagnostics: Quest Diagnostics is the largest US clinical lab and offers extensive reproductive and hereditary cancer genetic testing. Comparable to Metis as a national testing-and-results provider that competes for the same patient demand for test interpretation and counseling.
• GeneDx: GeneDx is a clinical genomics lab focused on rare disease, hereditary cancer, and pediatric testing and offers genetic counseling resources. It is both a Metis integration partner and a partial competitor in the hereditary cancer counseling space.
• Color Health: Color provides genetic testing for hereditary cancer, heart, and medication response, and has built clinical services including genetic counseling. It is comparable to Metis in the hereditary cancer counseling segment but owns the testing layer rather than being lab-agnostic.
• Myriad Genetics: Myriad is an established molecular diagnostics company in hereditary cancer and reproductive health (including NIPT via its subsidiary). It bundles genetic counseling with its testing, making it a partner-and-competitor to Metis in the hereditary cancer segment.
• Natera: Natera is a major genetic testing lab (NIPT, oncology, organ health) that also offers genetic counseling services to its patients. It is both a Metis integration partner and a competitor, and represents the broader pattern of labs moving into counseling services.
• Labcorp: Labcorp is a national clinical laboratory network offering a broad menu of genetic tests including NIPT, hereditary cancer panels, and carrier screening. It is a Metis partner lab and a partial competitor given its scale, footprint, and ability to bundle counseling with testing.

Direct peers

• Genome Medical: Genome Medical is a nationwide telehealth genetic counseling and genomics medicine company serving patients, providers, and health systems. It is the closest direct competitor to Metis, offering video- and phone-based genetic counseling across multiple clinical areas with board-certified genetic counselors.
• InformedDNA: InformedDNA is one of the largest US providers of genetic counseling services delivered via telehealth and has worked with payors, health systems, and pharma. It directly overlaps with Metis in lab-agnostic, phone/video-based genetic counseling and competes for the same patient and health system relationships.

Emerging players

• 23andMe: 23andMe is a consumer-facing genetic testing company that introduces large numbers of consumers to their genetic data and increasingly surfaces clinical-grade reports. It overlaps with Metis in DTC, reproductive, and hereditary cancer context, and is a meaningful indirect competitor for at-home genetic interpretation demand.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genetics